| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $76.5M | $66.9M | $59.4M |
| YoY Revenue Growth % | +14.4% | +12.6% | — |
| Gross Profit | $32.3M | $27.5M | — |
| Gross Margin % | 42.2% | 41.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $509.8K | -$5.3M | -$1.5M |
| Operating Margin % | 0.7% | -7.9% | -2.5% |
| Net Income (GAAP) | -$28.1M | -$7.2M | -$1.5M |
| EBITDA (Normalized) | $2.1M | -$4.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $159.3K | -$3.9M | -$2.2M |
| Capital Expenditures (CapEx) | $1.9M | $1.3M | — |
| Free Cash Flow (FCF) | -$1.8M | -$5.2M | -$2.2M |
| FCF Margin % | -2.3% | -7.8% | -3.8% |
| Return on Invested Capital (ROIC %) | 2.4% | -45.0% | — |
| Cash & Short-Term Equivalents | $20.5M | $4.2M | — |
| Total Debt (Short + Long Term) | $8.0M | $11.9M | — |
| Total Stockholders' Equity | $29.1M | -$1.6M | — |